Geron Operating Margin from 2010 to 2026
| GERN Stock | USD 1.65 0.02 1.23% |
Check Geron financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Geron's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 22.3 M or Selling General Administrative of 176 M, as well as many indicators such as Price To Sales Ratio of 25.4, Dividend Yield of 0.0 or PTB Ratio of 7.71. Geron financial statements analysis is a perfect complement when working with Geron Valuation or Volatility modules.
Geron | Operating Margin | Build AI portfolio with Geron Stock |
Evaluating Geron's Operating Margin across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Geron's fundamental strength.
Latest Geron's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Geron over the last few years. It is Geron's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Geron's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.29) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Geron Operating Margin Regression Statistics
| Arithmetic Mean | (105.50) | |
| Coefficient Of Variation | (193.13) | |
| Mean Deviation | 128.28 | |
| Median | (29.15) | |
| Standard Deviation | 203.76 | |
| Sample Variance | 41,517 | |
| Range | 818 | |
| R-Value | (0.32) | |
| Mean Square Error | 39,665 | |
| R-Squared | 0.10 | |
| Significance | 0.21 | |
| Slope | (13.03) | |
| Total Sum of Squares | 664,271 |
Geron Operating Margin History
About Geron Financial Statements
Geron investors utilize fundamental indicators, such as Operating Margin, to predict how Geron Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. The company was incorporated in 1990 and is headquartered in Foster City, California. Geron Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 69 people.
Pair Trading with Geron
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Geron position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Geron will appreciate offsetting losses from the drop in the long position's value.Moving together with Geron Stock
Moving against Geron Stock
| 0.82 | OSE | OSE Pharma SA | PairCorr |
| 0.79 | RAC | Race Oncology | PairCorr |
| 0.79 | DRMA | Dermata Therapeutics | PairCorr |
| 0.66 | VCEL | Vericel Corp Ord | PairCorr |
| 0.64 | ABNX | Abionyx Pharma SA | PairCorr |
The ability to find closely correlated positions to Geron could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Geron when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Geron - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Geron to buy it.
The correlation of Geron is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Geron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Geron moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Geron can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Geron Correlation against competitors. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Will Biotechnology sector continue expanding? Could Geron diversify its offerings? Factors like these will boost the valuation of Geron. Market participants price Geron higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Geron data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.12) | Revenue Per Share | Quarterly Revenue Growth 0.671 | Return On Assets | Return On Equity |
Understanding Geron requires distinguishing between market price and book value, where the latter reflects Geron's accounting equity. The concept of intrinsic value - what Geron's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Geron's price substantially above or below its fundamental value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Geron's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.